1. Patient- centered care 2. Partnering (with patients, other providers, communities) 3. Quality improvement (measuring care delivery and outcomes; learning.

Slides:



Advertisements
Similar presentations
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Advertisements

1 Interprofessional Education (IPE) “.. Occurs when two or more professions learn with, from, and about each other to improve collaboration and the quality.
1 Interdisciplinary collaboration (IdC) within primary care teams Nicosia, May 2009 Paolo Tedeschi, Mes – Management & Health Lab Scuola Superiore S.Anna.
Tad P. Fisher Executive Vice President Florida Academy of Family Physicians Patient Centered Medical Home A Medicaid Managed Care Alternative.
Supporting people in Dorset to lead healthier lives Commissioning the Dorset Community Persistent Pain Management Service Why is it so Painful to Commission.
Disease State Management The Pharmacist’s Role
The Value of Medication Therapy Management Services
ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.
Drug Utilization Review (DUR)
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Pharmacist Collaborative Practice Privileges in Diabetes Management
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
Capacity Task Force Virginia Health Reform Initiative January 14, 2011
Clinical Pharmacy Basma Y. Kentab MSc..
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
What is a Physician Hospital Compact? A compact is an agreement that clearly states the commitment of the medical staff and hospital leadership to one.
Keith J. Mueller, Ph.D. Director, RUPRI Center for Rural Health Policy Analysis Head, Department of Health Management and Policy College of Public Health.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Physicians’ acceptance of pharmaceutical medication reviews in an institution for the Elderly Buchmann S 1, Krähenbühl J.M 2, Nyffeler R 3, Buchmann M.
Discharge planning – reducing admissions/re- admissions Jo Clarke, CPPE tutor 1.
Introduction To Pharmacy Practice
Pharmacy Services.
Module 3. Session DCST Clinical governance
Why are we learning this? How scientific knowledge (pharmacology, therapeutics) and clinical skills (measuring blood pressure, glucoses, drug information)
Pharmaceutical Economics Heng-Sim Lee RPh MS Director of Pharmacy, ChiaYi Branch, Taichung Veterans General Hospital Clinical Nutritional.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Efficiency improvement of primary care prescription by physicians - pharmacists cooperating in quality circles Ruggli M. 1, Nyffeler R. 3, Duay B. 4, Repond.
Looking for a new chronic care delivery model January 24th 2012 Irina Odnoletkova, Project Manager Innovations.
The Value of Medication Therapy Management Services.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
ISPOR POLAND CHAPTER Polish Society of Pharmacoeconomics (PTFe )
1 Visioning the 21 st Century Health System Kenneth I. Shine, MD National Health Information Infrastructure 2003: Developing a National Action Agenda for.
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
Integrated Care What do we stand to gain? Kim Sutherland, PhD Director, System and Thematic Reports 22 November 2014.
Expectations for the provision of medicines Dr Michel Buchmann FIP Vice President 48th GIRP Annual General Meeting 18th June 2007, GENEVA.
Occupational Health. Occupational Medicine Recognized Specialty Since 1949 Combines Clinical Skills With Toxicology, Epidemiology, Safety, Rehabilitation,
PharmaSuisse Models for Evidence-based Therapeutic Decision- making and Therapeutic Management Martine Ruggli Pharmacist FPH pharmaSuisse Switzerland.
Module 3. Session Clinical Audit Prepared by J Moorman.
Objective the aim of this project was directly addressing a major health problem for Jordan by producing a guideline as a pilot in which the strengths.
What Does Research Tell Us? Care Manager Roles in Depression Care.
Medication Therapy Management Programs in Community Pharmacy Community Pharmacy October 17, 2006 Kurt A. Proctor, Ph.D., RPh Chief Operating Officer Community.
The present situation and future prospects for the pharmacist’s renumeration in Switzerland: A reorientation toward new paid professionnal services Are.
National Strategy for Quality Improvement in Health Care June 15, 2011 Kana Enomoto Director Office of Policy, Planning, and Innovation.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
Quality and Safety Education for Nurses The QSEN Project.
Transitions of Care: Using Pharmacists as Part of Team Based Care Care Transformation Collaborative of R.I. TARA HIGGINS, PHARMD, CDOE, CVDOE CLINICAL.
Multidisciplinary Diabetes Team Activities in a 196 Bed Community Hospital Robin Southwood, Pharm.D, CDE and Beth Melvin, RD, MS, CDE.
Pharmacists’ Patient Care Process
Is drug pricing a problem? PHILIP J. SCHNEIDER MS, FASHP, FASPEN, FFIP PROFESSOR AND ASSOCIATE DEAN UNIVERSITY OF ARIZONA COLLEGE OF PHARMACY PHOENIX BIOMEDICAL.
Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Partnerships.
The Medicines Adherence and Waste Challenge Carol Roberts Director of Strategic Prescribing EAHSN and PrescQIPP.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Introduction 2. Pharmaceutical care is a professional patient care practice, which, when provided as an organized service, is experienced, documented,
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Documentation in Practice Dept. of Clinical Pharmacy.
Darragh O’Loughlin MPSI IPU Secretary General Irish Pharmaceutical Healthcare Association RDS, Dublin: 26 November 2013.
Clinical Quality Improvement: Achieving BP Control
Clinical Project Meeting
CONTROLLING THE COSTS OF HEMOPHILIA
Implementing the guideline
Community Pharmacy: Sharing Our Vision
Introduction to Clinical Pharmacy
National Pharmacy Practice Standards the Regulatory Role
Communication Skills Lecture 1-2
Provider and Member Education in Managed Care Pharmacy
Pharmacy practice and the healthcare system Ola Ali Nassr
Pharmaceutical care planning 2 Ola Ali Nassr
Presentation transcript:

1. Patient- centered care 2. Partnering (with patients, other providers, communities) 3. Quality improvement (measuring care delivery and outcomes; learning and adapting to change; translating evidence into practice) 4. Information and communication technology 5. Public health perspective (population-based care delivery, seamless care, primary health care-led systems, etc.) (2005) (2009) 5 core competencies to provide better care for patients living with chronic health problems The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

2 « Collaborative Pharmacy Practice is defined as the clinical practice where pharmacists collaborate with other health care professionals in order to care for patients, carers and public. » FIP Statement of Policy on Collaborative Pharmacy Practice Draft document actually in a processus of discussion FIP Statement of Policy on Collaborative Pharmacy Practice Draft document actually in a processus of discussion Five levels of CPP have been identified from a number of models across the world AdveAdve Advanced CPP; authority to initiate or modify medicine therapy. Prospective advice and/or referral by another healthcare professional. Reactive advice to other health care professionals. System wide authority to supply medicines. Minimal contact between pharmacists and other healthcare professionals Degree of collaboration Amount of responsability The pharmacist’s perspectives o f the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

The five dimensions of Patient-centered care and their objectives (A. Niquille and O. Bugnon, Niquille’s PhD Thesis 2009, Geneva University) Quality of life Clinical outcomes Efficiency Public Health Quality Care Effectiveness Safety Patient Disease(s) Health Economics and Policy Health Care workforce Therapy(ies) The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

Strategy for implementation of collaborative care practice in primary care (O. Bugnon and M. Buchmann, 2010) 4 Implementation in primary care Advancement of collaborative care practice EDUCATION & COACHING (transfer from research into practice) EDUCATION & COACHING (transfer from research into practice) REGULATION for carers and patients (health policy; remuneration; quality standards; monitoring) REGULATION for carers and patients (health policy; remuneration; quality standards; monitoring) RESEARCH & DEVELOPMENT ( frameworks; methods and standards of practice; technologies; management; outcomes research ) RESEARCH & DEVELOPMENT ( frameworks; methods and standards of practice; technologies; management; outcomes research )

Examples of community pharmacists contributing to improvement of Patient-centred medication-use process The pharmacist’s perspectives of the team approach in Patient- centered Health Care Dr Pharm Michel Buchmann

A stable group of 3-10 GPs and 1-2 pharmacists as moderators Volunteers to have meetings together Evaluation of the daily prescribing practice Based on their own and actual prescription data Working together for continuously improving their practice Implementing practice guidelines and standards A continuous monitoring and feedback of the success of the common decisions that have been taken This means that every participant is active! What is a Physicians-Pharmacists Quality Circle ? (PPQC) ? The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

Working process within a PPQC ? The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

Community pharmacists and GPs together to lower the health costs Medications: «Implemented since 2002, pharmaceutical care services have allowed to decrease the costs in a spectacular way » The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

1st axe of collaborative care  practice guidelines and interdisciplinary education programmes The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

Niquille A. Ruggli M., Buchmann M., Jordan D. and Bugnon O. A nine- year sustained cost-containment impact of Swiss pilot physicians-pharmacists quality circles. The Annals of Pharmacotherapy, in press Locca J.-F., Ruggli M., Buchmann M., Huguenin J. and Bugnon O. Development of pharmaceutical care services in nursing homes: practice and research in a Swiss canton. Pharm World Sci (2008). PMID: Locca J.-F., Bula C., Zumbach S and Bugnon O. Pharmacological treatment of behavioral and psychological symptoms of dementia (BPSD) in nursing homes: development of practice recommendations in a Swiss canton. JAMDA (2008 Jul);9 (6): To know more about the « Physicians- Pharmacists Quality Circles » … The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

Examples of community pharmacists contributing to improvement of Patient-centred medication-use process The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

-Medication Event Monitoring System (MEMS®) : objective and dynamic measure of daily medication intake. -LCD display. 2. Adherence measurement 3. Adherence Report and record -Data collection, visualization and interpretation. -Feedback to the patient. -Quality management system - Interface with patient’s records. 1. Motivational interviewing patient- pharmacist -Individualized cognitive and behavioral intervention. -Seamless monitoring of medication adherence, adverse events and co- treatments in relation to health outcomes. Community pharmacy remunerated service for supporting patient adherence (Switzerland) The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

Examples of results of community pharmacists-led supporting patient adherence programs (Switzerland) 1. HIV patients Examples of results of community pharmacists-led supporting patient adherence programs (Switzerland) 1. HIV patients I. Krummenacher’s PhD thesis (2010)/ Pharmacie de la PMU, Lausanne (Switzerland)

Examples of results of community pharmacists-led supporting patient adherence programs (Switzerland) 2. Hypertensive patients Examples of results of community pharmacists-led supporting patient adherence programs (Switzerland) 2. Hypertensive patients H. Figueiredo’s PhD thesis (2010)/ Pharmacie de la PMU, Lausanne (Switzerland)

Schneider M.P., Krummenacher I., Figueiredo H., Marquis J. and Bugnon O. Adherence : a review of education, research, practice and policy in Switzerland. Pharmacy Practice 2009; 7 (2): Recent posters: Krummenacher I., Cavassini M., Bugnon O., Schneider M.P. Retrospective analysis of an HIV-adherence program. The 13th edition of the European Symposium on PAtient COMpliance and Persistence 2009 ESPACOMP, Bangor (Wales), Guignard Hefti E., Achtari Jeanneret L., Lange A.C., Vrijens B., Luthi F., Bugnon O., Schneider M.P. Adherence to oral anticancer treatment : focus on persistence and execution during continuous schema of treatment. 30st European Society of Clinical Pharmacy (ESCP) and GSASA symposium, Geneva, 4-6 Nov To know more about the Swiss « patient adherence programmes » … To know more about the Swiss « patient adherence programmes » … The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

In relation to physicians working alone, the main points are the following: A real collaborative practice is not a dream, The objectives are to optimize the safety and effectiveness of the treatments for the patients. A need to be persistent for best results An important saving capacity on medicines costs based on professional decisions and not on price reductions. An increased resistance of the Health workers against industrial marketing activities. A recognized interdisciplinary education in favor of person- centered care. A more efficient spreading or the pharmacovigilance messages. Swiss physicians-pharmacists collaborative practices Results in short lines... The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

Messages to be taken from this presentation  FIP, in his mission of the pharmaceutical world leader, is determined to open ways for collaborative practice within the health care team. FIP will clearly declare its intention by the adoption of a Statement of policy on Collaborative Pharmacy Practice during his next World Congress in Lisbon.  Swiss pharmacists are very active in the development of collaboration projects with physicians and nurses. They didn’t want to dream about it but really wanted to do it!  Person-centered care is evidence for us to improve the care and quality of lifes of our patients. It is evident to every decision makers that the future is clearly connected to collaborative practice because our societies will never have enough money to pay for ’all’ treatments. The building of this new world has to sprout up from beneath. We all have l the same responsabilities to support the change of our practices and of our attitudes. The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann

For the help received in preparing this presentation I want to thank: FIP, for the opportunity the represent our World Federation during this Conference. Prof Olivier Bugnon Phone: +41 (0) , Head of Community Pharmacy Practice Unit, Pharmaceutical Sciences Section (University of Geneva, University of Lausanne) My research and professional colleagues of the Pharmacie de la PMU, Rue du Bugnon 44, CH-1011 Lausanne (Switzerland) My friends physicians, pharmacists and nurses actually involved in all these new Swiss patient-centered projects The pharmacist’s perspectives of the team approach in Patient-centered Health Care Dr Pharm Michel Buchmann